Understanding Brain Cell Changes in Alzheimer's and Related Dementias

Project 3 - Astrocytic glutamate dysregulation in AD and VCID

NIH-funded research University of Kentucky · NIH-11126088

This project explores how a specific protein in brain support cells, called astrocytes, contributes to memory and thinking problems in Alzheimer's disease and similar conditions.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Kentucky NIH-funded
Lab location1 site (Lexington, United States)
Project IDNIH-11126088 on NIH RePORTER

What this research studies

Our brains rely on special support cells called astrocytes to keep things working smoothly, including clearing away a chemical called glutamate and providing energy. In Alzheimer's disease and related dementias, a protein in these astrocytes, EAAT2/Glt-1, often decreases, which might lead to too much glutamate and problems with energy supply to brain cells. This project aims to understand how this change affects blood flow in the brain, its energy use, and the overall communication between brain cells. By understanding these connections, we hope to uncover new ways to protect the brain from damage in these conditions.

Who could benefit from this research

Good fit: This foundational research is not directly recruiting patients but aims to benefit individuals living with Alzheimer's disease and other related dementias in the future.

Not a fit: Patients without Alzheimer's disease or related dementias would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to new treatment strategies that target astrocyte function to improve brain health and slow the progression of Alzheimer's and related dementias.

How similar studies have performed: Previous research has shown that the protein being studied is reduced in Alzheimer's disease, and similar mechanisms have been explored in other disease models, but its specific role in cerebrovascular function and brain metabolism in dementia is less understood.

Where this research is happening

Lexington, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.